Abbott Laboratories (ABT) plans nutrition spin-off to sharpen focus on medtech and pharma
FROM THE WIRE · GURUFOCUS.COM
On October 21, 2026, Abbott Laboratories (NYSE: ABT) announced its strategic decision to separate its Nutrition division into a standalone publicly traded compa
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralSpinning off a major division is a strategic move with implications for the group's future value.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Abbott Laboratories (NYSE: ABT) announced it will separate its Nutrition division.
- 02The division will become a standalone publicly traded company.
- 03The aim is to sharpen focus on medtech and pharmaceuticals.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets